메뉴 건너뛰기




Volumn 8, Issue 5, 2013, Pages 371-372

Laboratory tests during direct oral anticoagulant treatment? Yes

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

EID: 84880512821     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0949-3     Document Type: Editorial
Times cited : (15)

References (10)
  • 1
  • 2
    • 0036914221 scopus 로고    scopus 로고
    • Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance
    • Scordo MG, Pengo V, Spina E, Dahl ML, Gusella M, Padrini R (2002) Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance. Clin Pharmacol Ther 72: 702-710.
    • (2002) Clin Pharmacol Ther , vol.72 , pp. 702-710
    • Scordo, M.G.1    Pengo, V.2    Spina, E.3    Dahl, M.L.4    Gusella, M.5    Padrini, R.6
  • 4
    • 35348879239 scopus 로고    scopus 로고
    • Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)
    • Ezekowitz MD, Reilly PA, Nehmiz G et al (2007) Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol 100: 1419-1426.
    • (2007) Am J Cardiol , vol.100 , pp. 1419-1426
    • Ezekowitz, M.D.1    Reilly, P.A.2    Nehmiz, G.3
  • 5
    • 77950880770 scopus 로고    scopus 로고
    • Update on antithrombotic therapy. New anticoagulants
    • Eikelboom JW, Weitz JI (2010) Update on antithrombotic therapy. New anticoagulants. Circulation 121: 1523-1532.
    • (2010) Circulation , vol.121 , pp. 1523-1532
    • Eikelboom, J.W.1    Weitz, J.I.2
  • 8
    • 80053571188 scopus 로고    scopus 로고
    • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects
    • Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 124: 1573-1579.
    • (2011) Circulation , vol.124 , pp. 1573-1579
    • Eerenberg, E.S.1    Kamphuisen, P.W.2    Sijpkens, M.K.3    Meijers, J.C.4    Buller, H.R.5    Levi, M.6
  • 10
    • 80051579089 scopus 로고    scopus 로고
    • Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs
    • Kooiman J, van de Peppel WR, van der Meer FJ, Huisman MV (2011) Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs. J Thromb Haemost 9: 1652-1653.
    • (2011) J Thromb Haemost , vol.9 , pp. 1652-1653
    • Kooiman, J.1    van de Peppel, W.R.2    van der Meer, F.J.3    Huisman, M.V.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.